Comparison

Phospho-SPRY4(Y75) Antibody Blocking peptide

Manufacturer Abcepta
Category
Type Peptides
Specific against other
Format Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Amount 500 ug
Item no. ABC-BP3585a
eClass 6.1 34160400
eClass 9.0 32160409
Available
Primary Accession
Q9C004
Bio Background
SPRY4 is an inhibitor of the receptor-transduced mitogen-activated protein kinase (MAPK) signaling pathway. It is positioned upstream of RAS activation and impairs the formation of active GTP-RAS.
Bio References
Tsai CF, et al. (2008) J Proteome ResGuo A, et al. (2008) Proc Natl Acad Sci U S A 105, 692-7Rikova K, et al. (2007) Cell 131, 1190-203Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM (2007) Proc Natl Acad Sci U S A 104, 5860-5Tsumura Y, et al. (2005) Biochem J 387, 627-37
Gene ID
81848
Gene Name
SPRY4
Subtitle
Synthetic peptide
Target/Specificity
The synthetic peptide sequence used to generate the antibody AP3585a was selected from the region of human Phospho-SPRY4-pY75. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close